UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Current consensus on the management of primary sclerosing cholangitis

Clinics and research in hepatology and gastroenterology, 2011-12, Vol.35 (12), p.786-791

2011

Volltextzugriff (PDF)

Biliary Tract Cancer with or without Primary Sclerosing Cholangitis is Associated with a Raised Enhanced Liver Fibrosis Test Result Compared with PSC Alone

Journal of hepatology, 2016, Vol.64 (2), p.S722-S723

2016

Volltextzugriff (PDF)

P1174 : Microbiota-dependent marker trimethylamine-N-oxide (TMAO) is associated with the severity of primary sclerosing cholangitis

Journal of hepatology, 2015-04, Vol.62, p.S793-S794

2015

Volltextzugriff (PDF)

Novel Therapeutic Targets for Primary Sclerosing Cholangitis-Associated Biliary Tract Cancer Identified by Tissue Sequencing

JOURNAL OF HEPATOLOGY, 2016, Vol.64 (2), p.S225-S225

2016

Volltextzugriff (PDF)

Serological Biomarkers of Extracellular Matrix Remodeling Predict Transplant-Free Survival in Primary Sclerosing Cholangitis Patients

Journal of hepatology, 2016, Vol.64 (2), p.S199-S199

2016

Volltextzugriff (PDF)

Decreasing Incidence of Cancer after Liver Transplantation - A Nordic Population-Based Study

JOURNAL OF HEPATOLOGY, 2016, Vol.64 (2), p.S216-S217

2016

Volltextzugriff (PDF)

P1200 : The effect of azathioprine on the risk of malignancy in patients with primary sclerosing cholangitis: A long-term multicenter study

Journal of hepatology, 2015-04, Vol.62, p.S806-S806

2015

Volltextzugriff (PDF)

[112] GENETIC VARIATION IN THE RECEPTOR-LIGAND PAIR NKG2D-MICA IS STRONGLY ASSOCIATED WITH DEVELOPMENT OF CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

Journal of hepatology, 2007, Vol.46, p.S49-S49

2007

Volltextzugriff (PDF)

P363 ENHANCED LIVER FIBROSIS SCORE PREDICTS TRANSPLANT-FREE SURVIVAL IN PSC INDEPENDENTLY OF THE MAYO RISK SCORE

Journal of hepatology, 2014-04, Vol.60 (1), p.S188-S188

2014

Volltextzugriff (PDF)

O133 NOVEL PROTEIN MARKERS IDENTIFIED IN BILE AND SERUM ARE ASSOCIATED WITH A DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS, DISEASE SEVERITY, AND TRANSPLANT-FREE SURVIVAL

Journal of hepatology, 2014-04, Vol.60 (1), p.S55-S56

2014

Volltextzugriff (PDF)

318 INCREASED LEVELS OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN THE PLASMA OF CHOLANGIOCARCINOMA PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S130-S130

2012

Volltextzugriff (PDF)

22 ELECTROSTATIC MODIFICATIONS OF THE HLA-DR P9 PEPTIDE-BINDING POCKET AND SUSCEPTIBILITY TO PRIMARY SCLEROSING CHOLANGITIS

Journal of hepatology, 2011-03, Vol.54, p.S10-S11

2011

Volltextzugriff (PDF)

Acute liver graft rejection after ipilimumab therapy

Annals of oncology, 2017-10, Vol.28 (10), p.2619-2620

2017

Volltextzugriff (PDF)

102 NOVEL SUSCEPTIBILITY LOCI FOR PRIMARY SCLEROSING CHOLANGITIS IDENTIFIED BY GENOME-WIDE ASSOCIATION AND REPLICATION ANALYSIS

Journal of hepatology, 2011-03, Vol.54, p.S46-S46

2011

Volltextzugriff (PDF)

Decreasing incidence of cancer after liver transplantation—A Nordic population‐based study over 3 decades

American journal of transplantation, 2018-04, Vol.18 (4), p.952-963

2018

Volltextzugriff (PDF)

165 Array-based approach for early tumour detection in the biliary tract

European journal of cancer supplements, 2010, Vol.8 (5), p.44-44

2010

Volltextzugriff (PDF)

SAT-444 - Biliary Tract Cancer with or without Primary Sclerosing Cholangitis is Associated with a Raised Enhanced Liver Fibrosis Test Result Compared with PSC Alone

Journal of hepatology, 2016, Vol.64 (2), p.S722-S723

2016

Volltextzugriff (PDF)

Association of UCP2 −866 G A polymorphism with chronic inflammatory diseases

Genes and immunity, 2009-09, Vol.10 (6), p.601-605

2009

Volltextzugriff (PDF)

PS125 - Serological Biomarkers of Extracellular Matrix Remodeling Predict Transplant-Free Survival in Primary Sclerosing Cholangitis Patients

Journal of hepatology, 2016, Vol.64 (2), p.S199-S199

2016

Volltextzugriff (PDF)

LBP525 - Novel Therapeutic Targets for Primary Sclerosing Cholangitis-Associated Biliary Tract Cancer Identified by Tissue Sequencing

Journal of hepatology, 2016, Vol.64 (2), p.S225-S225

2016

Volltextzugriff (PDF)

LBP509 - Decreasing Incidence of Cancer after Liver Transplantation - A Nordic Population-Based Study

Journal of hepatology, 2016, Vol.64 (2), p.S216-S217

2016

Volltextzugriff (PDF)

Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis — What next?

Journal of Crohn's and colitis, 2014-05, Vol.8 (5), p.421-430

2014

Volltextzugriff (PDF)

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis

Genes and immunity, 2007-04, Vol.8 (3), p.275-278

2007

Volltextzugriff (PDF)

Genotype-Phenotype Analysis across 130,422 Genetic Variants Identifies Rspo3 as the First Genome-Wide Significant Modifier Gene in Primary Sclerosing Cholangitis

JOURNAL OF HEPATOLOGY, 2016, Vol.64 (2), p.S642-S643

2016

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(36)
Buchkapitel
(1)

Sprache

Englisch
(37)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(15)
Medicin Och Hälsovetenskap
(9)
Humans
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Female
(7)
Male
(6)
Adult
(5)
Middle Aged
(5)
Risk Factors
(5)
Cholangitis
(4)
Aged
(3)
Case-Control Studies
(3)
Cholangitis, Sclerosing - Complications
(3)
Cholangitis, Sclerosing - Genetics
(3)
Cholangitis, Sclerosing - Immunology
(3)
Gastroenterology & Hepatology
(3)
Immunology
(3)
Liver Transplantation
(3)
Ulcerative Colitis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current consensus on the management of primary sclerosing cholangitis

Biliary Tract Cancer with or without Primary Sclerosing Cholangitis is Associated with a Raised Enhanced Liver Fibrosis Test Result Compared with PSC Alone

P1174 : Microbiota-dependent marker trimethylamine-N-oxide (TMAO) is associated with the severity of primary sclerosing cholangitis

Novel Therapeutic Targets for Primary Sclerosing Cholangitis-Associated Biliary Tract Cancer Identified by Tissue Sequencing

Serological Biomarkers of Extracellular Matrix Remodeling Predict Transplant-Free Survival in Primary Sclerosing Cholangitis Patients

Decreasing Incidence of Cancer after Liver Transplantation - A Nordic Population-Based Study

P1200 : The effect of azathioprine on the risk of malignancy in patients with primary sclerosing cholangitis: A long-term multicenter study

O5 PRIMARY SCLEROSING CHOLANGITIS FROM A GLOBAL PERSPECTIVE – A MULTICENTER, RETROSPECTIVE, OBSERVATIONAL STUDY OF THE INTERNATIONAL PSC STUDY GROUP

[112] GENETIC VARIATION IN THE RECEPTOR-LIGAND PAIR NKG2D-MICA IS STRONGLY ASSOCIATED WITH DEVELOPMENT OF CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

P363 ENHANCED LIVER FIBROSIS SCORE PREDICTS TRANSPLANT-FREE SURVIVAL IN PSC INDEPENDENTLY OF THE MAYO RISK SCORE

O133 NOVEL PROTEIN MARKERS IDENTIFIED IN BILE AND SERUM ARE ASSOCIATED WITH A DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS, DISEASE SEVERITY, AND TRANSPLANT-FREE SURVIVAL

318 INCREASED LEVELS OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN THE PLASMA OF CHOLANGIOCARCINOMA PATIENTS

22 ELECTROSTATIC MODIFICATIONS OF THE HLA-DR P9 PEPTIDE-BINDING POCKET AND SUSCEPTIBILITY TO PRIMARY SCLEROSING CHOLANGITIS

Acute liver graft rejection after ipilimumab therapy

102 NOVEL SUSCEPTIBILITY LOCI FOR PRIMARY SCLEROSING CHOLANGITIS IDENTIFIED BY GENOME-WIDE ASSOCIATION AND REPLICATION ANALYSIS

Decreasing incidence of cancer after liver transplantation—A Nordic population‐based study over 3 decades

165 Array-based approach for early tumour detection in the biliary tract

SAT-444 - Biliary Tract Cancer with or without Primary Sclerosing Cholangitis is Associated with a Raised Enhanced Liver Fibrosis Test Result Compared with PSC Alone

Association of UCP2 −866 G A polymorphism with chronic inflammatory diseases

PS125 - Serological Biomarkers of Extracellular Matrix Remodeling Predict Transplant-Free Survival in Primary Sclerosing Cholangitis Patients

LBP525 - Novel Therapeutic Targets for Primary Sclerosing Cholangitis-Associated Biliary Tract Cancer Identified by Tissue Sequencing

LBP509 - Decreasing Incidence of Cancer after Liver Transplantation - A Nordic Population-Based Study

Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis — What next?

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis

Genotype-Phenotype Analysis across 130,422 Genetic Variants Identifies Rspo3 as the First Genome-Wide Significant Modifier Gene in Primary Sclerosing Cholangitis

Suchergebnisse filtern